Interactome Analyses Revealed That the U1 Snrnp Machinery Overlaps
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Astrin-SKAP Complex Reconstitution Reveals Its Kinetochore
RESEARCH ARTICLE Astrin-SKAP complex reconstitution reveals its kinetochore interaction with microtubule-bound Ndc80 David M Kern1,2, Julie K Monda1,2†, Kuan-Chung Su1†, Elizabeth M Wilson-Kubalek3, Iain M Cheeseman1,2* 1Whitehead Institute for Biomedical Research, Cambridge, United States; 2Department of Biology, Massachusetts Institute of Technology, Cambridge, United States; 3Department of Cell Biology, The Scripps Research Institute, La Jolla, United States Abstract Chromosome segregation requires robust interactions between the macromolecular kinetochore structure and dynamic microtubule polymers. A key outstanding question is how kinetochore-microtubule attachments are modulated to ensure that bi-oriented attachments are selectively stabilized and maintained. The Astrin-SKAP complex localizes preferentially to properly bi-oriented sister kinetochores, representing the final outer kinetochore component recruited prior to anaphase onset. Here, we reconstitute the 4-subunit Astrin-SKAP complex, including a novel MYCBP subunit. Our work demonstrates that the Astrin-SKAP complex contains separable kinetochore localization and microtubule binding domains. In addition, through cross-linking analysis in human cells and biochemical reconstitution, we show that the Astrin-SKAP complex binds synergistically to microtubules with the Ndc80 complex to form an integrated interface. We propose a model in which the Astrin-SKAP complex acts together with the Ndc80 complex to stabilize correctly formed kinetochore-microtubule interactions. *For correspondence: DOI: https://doi.org/10.7554/eLife.26866.001 [email protected] †These authors contributed equally to this work Introduction Competing interests: The The macromolecular kinetochore complex links chromosomes to dynamic microtubule polymers and authors declare that no harnesses the forces generated by microtubule growth and depolymerization to facilitate accurate competing interests exist. -
Identification of the Causative Gene for Simmental Arachnomelia Syndrome Using a Network-Based Disease Gene Prioritization Approach
Identification of the Causative Gene for Simmental Arachnomelia Syndrome Using a Network-Based Disease Gene Prioritization Approach Shihui Jiao1., Qin Chu2., Yachun Wang1*, Zhenquan Xie3, Shiyu Hou3, Airong Liu5, Hongjun Wu4, Lin Liu6, Fanjun Geng7, Congyong Wang7, Chunhua Qin8, Rui Tan9, Xixia Huang10, Shixin Tan11, Meng Wu12, Xianzhou Xu12, Xuan Liu1, Ying Yu1, Yuan Zhang1 1 Key Laboratory of Agricultural Animal and Breeding, National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, China, 2 Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agriculture and Forestry Sciences, Beijing, China, 3 Anshan Hengli Dairy Farm, Anshan, Liaoning, China, 4 Xiertala Breeding Farm, Hailaer Farm Buro, Hailaer, Inner Mongolia, China, 5 Hailaer Farm Buro, Hailaer, Inner Mongolia, China, 6 Beijing Dairy Cattle Centre, Beijing, China, 7 Dingyuan Seedstock Bulls Breeding Ltd. Company, Zhengzhou, Henan, China, 8 Ningxia Sygen BioEngineering Research Center, Yinchuan, Ningxia, China, 9 Xinjiang General Livestock Service, Urumqi, Xinjiang, China, 10 College of Animal Science, Xinjiang Agriculture University, Urumqi, Xinjiang, China, 11 Xinjiang Tianshan Animal Husbandry Bio-engineering Co. Ltd, Urumqi, Xinjiang, China, 12 Dalian Xuelong Industry Limited Group, Dalian, Liaoning, China Abstract Arachnomelia syndrome (AS), mainly found in Brown Swiss and Simmental cattle, is a congenital lethal genetic malformation of the skeletal system. In this study, a network-based disease gene prioritization approach was implemented to rank genes in the previously reported ,7 Mb region on chromosome 23 associated with AS in Simmental cattle. The top 6 ranked candidate genes were sequenced in four German Simmental bulls, one known AS-carrier ROMEL and a pooled sample of three known non-carriers (BOSSAG, RIFURT and HIRMER). -
Cyclin D1 Is a Direct Transcriptional Target of GATA3 in Neuroblastoma Tumor Cells
Oncogene (2010) 29, 2739–2745 & 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 $32.00 www.nature.com/onc SHORT COMMUNICATION Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells JJ Molenaar1,2, ME Ebus1, J Koster1, E Santo1, D Geerts1, R Versteeg1 and HN Caron2 1Department of Human Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands and 2Department of Pediatric Oncology, Emma Kinderziekenhuis, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Almost all neuroblastoma tumors express excess levels of 2000). Several checkpoints normally prevent premature Cyclin D1 (CCND1) compared to normal tissues and cell-cycle progression and cell division. The crucial G1 other tumor types. Only a small percentage of these entry point is controlled by the D-type Cyclins that can neuroblastoma tumors have high-level amplification of the activate CDK4/6 that in turn phosphorylate the pRb Cyclin D1 gene. The other neuroblastoma tumors have protein. This results in a release of the E2F transcription equally high Cyclin D1 expression without amplification. factor that causes transcriptional upregulation of Silencing of Cyclin D1 expression was previously found to numerous genes involved in further progression of the trigger differentiation of neuroblastoma cells. Over- cell cycle (Sherr, 1996). expression of Cyclin D1 is therefore one of the most Neuroblastomas are embryonal tumors that originate frequent mechanisms with a postulated function in neuro- from precursor cells of the sympathetic nervous system. blastoma pathogenesis. The cause for the Cyclin D1 This tumor has a very poor prognosis and despite the overexpression is unknown. -
Dietary Supplementation with L-Arginine, Single Nucleotide
The Journal of Nutrition Commentary Dietary Supplementation with L-Arginine, Single Nucleotide Polymorphisms of Arginase Downloaded from https://academic.oup.com/jn/advance-article/doi/10.1093/jn/nxaa431/6131937 by University of Memphis - Library user on 10 February 2021 1 and 2, and Plasma L-Arginine Keith R Martin Center for Nutraceutical and Dietary Supplement Research, College of Health Sciences, University of Memphis, Memphis, TN, USA There are ∼3 million single nucleotide polymorphisms (SNPs) Arginine-dependent NO impacts the immune, neuronal, and between 2 unrelated individuals, with each SNP representing cardiovascular systems and is a potent vasodilator critical for a single modification in the genomic code and cumulatively vascular tone, blood pressure modulation, vascular permeabil- representing 0.1% human genetic diversity. Although many of ity, and angiogenesis (7–9). SNPs in the ARG1 gene are clinically these differences are silent, relatively recent data suggest that associated with cardiovascular diseases such as hypertension, around half of the various responses to dietary agents could cardiomyopathy, myocardial infarction, and carotid intima be related to genetic variation, a field coined as nutrigenetics. media thickness, and upregulation of arginase is implicated in These variations are of considerable interest in improving the vascular dysfunction (10, 11). Thus, dietary supplementation health of individuals and collectively mitigating the risk of with l-arginine could be warranted. chronic disease. In this issue of the Journal, Hannemann et The study by Hannemann et al. is the first to describe al. (1) describe a possible functional relation between arginase an association between genotypes of ARG1 and ARG2 with isoforms, important in the urea cycle and nitric oxide (NO) consequent circulating plasma concentrations of l-arginine. -
Mesenchymal Stem Cells Prevent the Progression of Diabetic
Lee et al. Experimental & Molecular Medicine (2019) 51:77 https://doi.org/10.1038/s12276-019-0268-5 Experimental & Molecular Medicine ARTICLE Open Access Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells Seung Eun Lee1,2,7,JungEunJang1,2,8,HyunSikKim2,MinKyoJung2,MyoungSeokKo2,Mi-OkKim2, Hye Sun Park2, Wonil Oh3, Soo Jin Choi3,HyeJinJin3, Sang-Yeob Kim4,YunJaeKim2,SeongWhoKim5, Min Kyung Kim5, Chang Ohk Sung6, Chan-Gi Pack 2,Ki-UpLee1,2 and Eun Hee Koh1,2 Abstract The administration of mesenchymal stem cells (MSCs) was shown to attenuate overt as well as early diabetic nephropathy in rodents, but the underlying mechanism of this beneficial effect is largely unknown. Inflammation and mitochondrial dysfunction are major pathogenic factors in diabetic nephropathy. In this study, we found that the repeated administration of MSCs prevents albuminuria and injury to tubular epithelial cells (TECs), an important element in the progression of diabetic nephropathy, by improving mitochondrial function. The expression of M1 macrophage markers was significantly increased in diabetic kidneys compared with that in control kidneys. Interestingly, the expression of arginase-1 (Arg1), an important M2 macrophage marker, was reduced in diabetic kidneys and increased by MSC treatment. In cultured TECs, conditioned media from lipopolysaccharide-activated 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; macrophages reduced peroxisomal proliferator-activated receptor gamma coactivator 1α (Pgc1a) expression and impaired mitochondrial function. The coculture of macrophages with MSCs increased and decreased the expression of Arg1 and M1 markers, respectively. Treatment with conditioned media from cocultured macrophages prevented activated macrophage-induced mitochondrial dysfunction in TECs. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Hypopituitarism May Be an Additional Feature of SIM1 and POU3F2 Containing 6Q16 Deletions in Children with Early Onset Obesity
Open Access Journal of Pediatric Endocrinology Case Report Hypopituitarism may be an Additional Feature of SIM1 and POU3F2 Containing 6q16 Deletions in Children with Early Onset Obesity Rutteman B1, De Rademaeker M2, Gies I1, Van den Bogaert A2, Zeevaert R1, Vanbesien J1 and De Abstract Schepper J1* Over the past decades, 6q16 deletions have become recognized as a 1Department of Pediatric Endocrinology, UZ Brussel, frequent cause of the Prader-Willi-like syndrome. Involvement of SIM1 in the Belgium deletion has been linked to the development of obesity. Although SIM1 together 2Department of Genetics, UZ Brussel, Belgium with POU3F2, which is located close to the SIM1 locus, are involved in pituitary *Corresponding author: De Schepper J, Department development and function, pituitary dysfunction has not been reported frequently of Pediatric Endocrinology, UZ Brussel, Belgium in cases of 6q16.1q16.3 deletion involving both genes. Here we report on a case of a girl with typical Prader-Willi-like symptoms including early-onset Received: December 23, 2016; Accepted: February 21, hyperphagic obesity, hypotonia, short hands and feet and neuro-psychomotor 2017; Published: February 22, 2017 development delay. Furthermore, she suffered from central diabetes insipidus, central hypothyroidism and hypocortisolism. Her genetic defect is a 6q16.1q16.3 deletion, including SIM1 and POU3F2. We recommend searching for a 6q16 deletion in children with early onset hyperphagic obesity associated with biological signs of hypopituitarism and/or polyuria-polydipsia syndrome. The finding of a combined SIM1 and POU3F2 deletion should prompt monitoring for the development of hypopituitarism, if not already present at diagnosis. Keywords: 6q16 deletion; SIM1; POU3F2; Prader-Willi-like syndrome; Hypopituitarism Introduction insipidus and of some specific pituitary hormone deficiencies in children with a combined SIM1 and POU3F2 deficiency. -
(BCLAF1) ELISA Kit Catalogue No.:Abx503645
Datasheet Version: 1.0.0 Revision date: 14 Jan 2021 Human Bcl-2-associated transcription factor 1 (BCLAF1) ELISA Kit Catalogue No.:abx503645 Human Bcl-2-associated transcription factor 1 (BCLAF1) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Bcl-2-associated transcription factor 1 (BCLAF1) concentrations in tissue homogenates, cell lysates and other biological fluids. Target: Bcl-2-associated transcription factor 1 (BCLAF1) Reactivity: Human Tested Applications: ELISA Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user. Storage: Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual. Validity: The validity for this kit is 6 months. Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout. UniProt Primary AC: Q9NYF8 (UniProt, ExPASy) Gene Symbol: ForBCLAF1 Reference Only KEGG: hsa:9774 Test Range: 0.156 ng/ml - 10 ng/ml Standard Form: Lyophilized ELISA Detection: Colorimetric v1.0.0 Abbexa Ltd, Cambridge, UK · Phone: +44 1223 755950 · Fax: +44 1223 755951 1 Abbexa LLC, Houston, TX, USA · Phone: +1 832 327 7413 www.abbexa.com · Email: [email protected] Datasheet Version: 1.0.0 Revision date: 14 Jan 2021 ELISA Data: Quantitative Sample Type: Tissue homogenates, cell lysates and other biological fluids. Note: This product is for research use only. -
Whole Exome Sequencing in ADHD Trios from Single and Multi-Incident Families Implicates New Candidate Genes and Highlights Polygenic Transmission
European Journal of Human Genetics (2020) 28:1098–1110 https://doi.org/10.1038/s41431-020-0619-7 ARTICLE Whole exome sequencing in ADHD trios from single and multi-incident families implicates new candidate genes and highlights polygenic transmission 1,2 1 1,2 1,3 1 Bashayer R. Al-Mubarak ● Aisha Omar ● Batoul Baz ● Basma Al-Abdulaziz ● Amna I. Magrashi ● 1,2 2 2,4 2,4,5 6 Eman Al-Yemni ● Amjad Jabaan ● Dorota Monies ● Mohamed Abouelhoda ● Dejene Abebe ● 7 1,2 Mohammad Ghaziuddin ● Nada A. Al-Tassan Received: 26 September 2019 / Revised: 26 February 2020 / Accepted: 10 March 2020 / Published online: 1 April 2020 © The Author(s) 2020. This article is published with open access Abstract Several types of genetic alterations occurring at numerous loci have been described in attention deficit hyperactivity disorder (ADHD). However, the role of rare single nucleotide variants (SNVs) remains under investigated. Here, we sought to identify rare SNVs with predicted deleterious effect that may contribute to ADHD risk. We chose to study ADHD families (including multi-incident) from a population with a high rate of consanguinity in which genetic risk factors tend to 1234567890();,: 1234567890();,: accumulate and therefore increasing the chance of detecting risk alleles. We employed whole exome sequencing (WES) to interrogate the entire coding region of 16 trios with ADHD. We also performed enrichment analysis on our final list of genes to identify the overrepresented biological processes. A total of 32 rare variants with predicted damaging effect were identified in 31 genes. At least two variants were detected per proband, most of which were not exclusive to the affected individuals. -
Genome-Wide Association Study for Circulating Fibroblast Growth Factor
www.nature.com/scientificreports OPEN Genome‑wide association study for circulating fbroblast growth factor 21 and 23 Gwo‑Tsann Chuang1,2,14, Pi‑Hua Liu3,4,14, Tsui‑Wei Chyan5, Chen‑Hao Huang5, Yu‑Yao Huang4,6, Chia‑Hung Lin4,7, Jou‑Wei Lin8, Chih‑Neng Hsu8, Ru‑Yi Tsai8, Meng‑Lun Hsieh9, Hsiao‑Lin Lee9, Wei‑shun Yang2,9, Cassianne Robinson‑Cohen10, Chia‑Ni Hsiung11, Chen‑Yang Shen12,13 & Yi‑Cheng Chang2,9,12* Fibroblast growth factors (FGFs) 21 and 23 are recently identifed hormones regulating metabolism of glucose, lipid, phosphate and vitamin D. Here we conducted a genome‑wide association study (GWAS) for circulating FGF21 and FGF23 concentrations to identify their genetic determinants. We enrolled 5,000 participants from Taiwan Biobank for this GWAS. After excluding participants with diabetes mellitus and quality control, association of single nucleotide polymorphisms (SNPs) with log‑transformed FGF21 and FGF23 serum concentrations adjusted for age, sex and principal components of ancestry were analyzed. A second model additionally adjusted for body mass index (BMI) and a third model additionally adjusted for BMI and estimated glomerular fltration rate (eGFR) were used. A total of 4,201 participants underwent GWAS analysis. rs67327215, located within RGS6 (a gene involved in fatty acid synthesis), and two other SNPs (rs12565114 and rs9520257, located between PHC2-ZSCAN20 and ARGLU1-FAM155A respectively) showed suggestive associations with serum FGF21 level (P = 6.66 × 10–7, 6.00 × 10–7 and 6.11 × 10–7 respectively). The SNPs rs17111495 and rs17843626 were signifcantly associated with FGF23 level, with the former near PCSK9 gene and the latter near HLA-DQA1 gene (P = 1.04 × 10–10 and 1.80 × 10–8 respectively). -
Controls Homeostatic Splicing of ARGLU1 Mrna Stephan P
Published online 28 November 2016 Nucleic Acids Research, 2017, Vol. 45, No. 6 3473–3486 doi: 10.1093/nar/gkw1140 An Ultraconserved Element (UCE) controls homeostatic splicing of ARGLU1 mRNA Stephan P. Pirnie, Ahmad Osman, Yinzhou Zhu and Gordon G. Carmichael* Department of Genetics and Genome Sciences, UCONN Health Center, 400 Farmington Avenue, Farmington, CT 06030, USA Received January 13, 2016; Revised October 25, 2016; Editorial Decision October 28, 2016; Accepted October 31, 2016 ABSTRACT or inhibit the usage of a particular splice site (1,2). The ex- pression of trans-acting factors in a developmental and tis- Arginine and Glutamate-Rich protein 1 (ARGLU1) is sue specific manner results in regulated splicing that isof- a protein whose function is poorly understood, but ten cell specific. Most notably, trans-acting proteins such as may act in both transcription and pre-mRNA splicing. the NOVA (3–6), the RBFOX (7) and SR protein (8–11) We demonstrate that the ARGLU1 gene expresses families, and a number of hnRNP (12,13) proteins compete at least three distinct RNA splice isoforms – a fully to bind nascent RNAs at specific motifs and drive regula- spliced isoform coding for the protein, an isoform tion of alternative splicing in a tissue and developmentally containing a retained intron that is detained in the specific manner. Alternative splicing is an important pro- nucleus, and an isoform containing an alternative cess that is seen in at least 95% of multi-exon genes in the exon that targets the transcript for nonsense medi- human transcriptome (14). Furthermore, alternative splic- ated decay. -
S41467-020-18249-3.Pdf
ARTICLE https://doi.org/10.1038/s41467-020-18249-3 OPEN Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain Lei Zhao1,2,17, Zhongqi Li 1,2,17, Joaquim S. L. Vong2,3,17, Xinyi Chen1,2, Hei-Ming Lai1,2,4,5,6, Leo Y. C. Yan1,2, Junzhe Huang1,2, Samuel K. H. Sy1,2,7, Xiaoyu Tian 8, Yu Huang 8, Ho Yin Edwin Chan5,9, Hon-Cheong So6,8, ✉ ✉ Wai-Lung Ng 10, Yamei Tang11, Wei-Jye Lin12,13, Vincent C. T. Mok1,5,6,14,15 &HoKo 1,2,4,5,6,8,14,16 1234567890():,; The molecular signatures of cells in the brain have been revealed in unprecedented detail, yet the ageing-associated genome-wide expression changes that may contribute to neurovas- cular dysfunction in neurodegenerative diseases remain elusive. Here, we report zonation- dependent transcriptomic changes in aged mouse brain endothelial cells (ECs), which pro- minently implicate altered immune/cytokine signaling in ECs of all vascular segments, and functional changes impacting the blood–brain barrier (BBB) and glucose/energy metabolism especially in capillary ECs (capECs). An overrepresentation of Alzheimer disease (AD) GWAS genes is evident among the human orthologs of the differentially expressed genes of aged capECs, while comparative analysis revealed a subset of concordantly downregulated, functionally important genes in human AD brains. Treatment with exenatide, a glucagon-like peptide-1 receptor agonist, strongly reverses aged mouse brain EC transcriptomic changes and BBB leakage, with associated attenuation of microglial priming. We thus revealed tran- scriptomic alterations underlying brain EC ageing that are complex yet pharmacologically reversible.